Russian Pneumonic Plague
CDC October 6 2026: CDC is aware of and closely monitoring reports of a suspected case of pneumonic plague in the Irkutsk region of Russia that resulted in a death. We are working across the U.S. government to assess developments as additional information becomes available.
While the circumstances of this reported case remain unconfirmed, plague is a serious bacterial disease that is treatable with antibiotics, particularly when recognized and treated early.
CDC is aware of and closely monitoring reports of a suspected case of pneumonic plague in the Irkutsk region of Russia that resulted in a death. We are working across the U.S. government to assess developments as additional information becomes available. While the circumstances of this reported case remain unconfirmed, plague is a serious bacterial disease that is treatable with antibiotics, particularly when recognized and treated early. Pneumonic plague can spread person-to-person through respiratory droplets during close contact, which is why rapid identification and treatment of infected individuals, and monitoring of potentially exposed individuals, are important public health measures. At this time, there is no indication of a broader threat to the United States, but CDC and our interagency partners are prepared and will continue to monitor the situation closely.
— CDC (@CDCgov) October 6, 2026
EXC: The director of Russia's Irkutsk anti-plague institute was in CHINA just weeks ago for a "cross-border infectious disease" exercise that simulated responses to imported PLAGUE and "Disease X." About five weeks later, an employee of his institute was dead, with nearly 200 contacts reportedly placed under medical observation amid suspected-plague reports. Chinese government reporting names director Sergey Balakhonov as attending and speaking at the August 24–27 exercise in Fuyuan. The Chinese exercise involved the following: • A scenario involving plague arriving from abroad. • A hypothetical emerging tick-borne disease. • Chinese and Russian experts rehearsing outbreak notifications, joint risk assessments, and coordinated control measures. • Nineteen emergency teams, more than 300 personnel, and over 40 emergency vehicles.
EXC: The director of Russia’s Irkutsk anti-plague institute was in CHINA just weeks ago for a “cross-border infectious disease” exercise that simulated responses to imported PLAGUE and “Disease X.” About five weeks later, an employee of his institute was dead, with nearly 200 contacts reportedly placed under medical observation amid suspected-plague reports. Chinese government reporting names director Sergey Balakhonov as attending and speaking at the August 24–27 exercise in Fuyuan. The Chinese exercise involved the following: • A scenario involving plague arriving from abroad. • A hypothetical emerging tick-borne disease. • Chinese and Russian experts rehearsing outbreak notifications, joint risk assessments, and coordinated control measures. • Nineteen emergency teams, more than 300 personnel, and over 40 emergency vehicles. And the institute’s Chinese partnerships go back years. China’s official Inner Mongolia Yearbook records that regional inspection and quarantine authorities signed scientific-research cooperation agreements with the Irkutsk plague institute in 2014. A Russian government document lists additional cooperation planned for 2020–2021 with the Medical Department of Manzhouli Customs: joint surveys concerning plague and other rodent-borne infections, plus tick-borne disease research.
— Natalie Winters (@nataliegwinters) October 5, 2026
New York Post
Suspected pneumonic plague outbreak erupts in Russia after scientist dies https://t.co/Z22a1RjeR9 https://t.co/dOmbltROH2
— New York Post (@nypost) October 5, 2026
Doxycycline treats PLAGUE with a 97% SURVIVAL RATE. 29 of 30 survived in a randomized clinical trial. This is not the Middle Ages.
Doxycycline treats PLAGUE with a 97% SURVIVAL RATE. 29 of 30 survived in a randomized clinical trial. This is not the Middle Ages.
— Nicolas Hulscher, MPH (@NicHulscher) October 5, 2026